Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling.

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Abstract Text:

Steven N Mink,Zhao-Qin Cheng,Ratna Bose,Hans Jacobs,Krika Kasian,Diane E Roberts,Luis E Santos-Martinez,R Bruce Light,Steven N Mink,Zhao-Qin Cheng,Ratna Bose,Hans Jacobs,Krika Kasian,Diane E Roberts,Luis E Santos-Martinez,R Bruce Light,

We previously showed that lysozyme (Lzm-S), derived from leukocytes, caused myocardial depression in canine sepsis by binding to the endocardial endothelium to release nitric oxide (NO). NO then diffuses to adjacent myocytes to activate the cGMP pathway. In a canine right ventricular trabecular (RVT) preparation, Lzm-S also decreased the inotropic response to field stimulation (FSR) during which the sympathetic and parasympathetic nerves were simulated to measure the adrenergic response. In the present study, we determined whether the pathway by which Lzm-S decreased FSR was different from the pathway by which Lzm-S reduced steady-state (SS) contraction. Furthermore, we determined whether the decrease in FSR was due to a decrease in sympathetic stimulation or enhanced parasympathetic signaling. In the RVT preparation, we found that the inhibitory effect of Lzm-S on FSR was prevented by NO synthase (NOS) inhibitors. A cGMP inhibitor also blocked the depressant activity of Lzm-S. However, in contrast to the Lzm-S-induced decline in SS contraction, chemical removal of the endocardial endothelium by Triton X-100 to eliminate endothelial NO release did not prevent the decrease in FSR. An inhibitory G protein was involved in the effect of Lzm-S, since FSR could be restored by treatment with pertussis toxin. Atropine prevented the Lzm-S-induced decline in FSR, whereas beta(1)- and beta(2)-adrenoceptor function was not impaired by Lzm-S. These results indicate that the Lzm-S-induced decrease in FSR results from a nonendothelial release of NO. NO then acts through inhibitory G protein to enhance parasympathetic signaling.

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Publishing Authors By Initials

SN Mink,ZQ Cheng,R Bose,H Jacobs,K Kasian,DE Roberts,LE Santos-Martinez,RB Light,SN Mink,ZQ Cheng,R Bose,H Jacobs,K Kasian,DE Roberts,LE Santos-Martinez,RB Light,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: American journal of physiology. Heart and circulat

VOLUME: 293

Page Numbers: H3140-9

Journal Abbreviation: Am. J. Physiol. Heart Circ. Ph

ISSN: 0363-6135

DAY: 31

MONTH: 08

YEAR: 2007

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100901228

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling.

AFFILIATION: Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. minksn@cc.umanitoba.ca

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Physiol Heart Circ Physio

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling Related Publications

• "A child needs to be given a chance to succeed": Parents of individuals who use AAC describe the benefits and challenges of learning AAC technologies.
• A record for the recovery room.
• An experimental study of the effect of heparin on the local pathology of burns.
• Anesthesia for extremity amputations; a statistical review of 185 major amputation cases.
• Anion binding vs. sulfonamide deprotonation in functionalised ureas.
• Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients.
• Cardiac KATP channels and ischemic preconditioning: current perspectives.
• Clinical manifestations of type IV ulna longitudinal dysplasia.
• Diagnostic utility of blood volume monitoring in hemodialysis patients.
• Effects of mild cardiovascular and cerebrovascular disorders on serial reaction time performance.
• Histological study of human scalps exhibiting various degrees of non-specific baldness.
• Influence of pain and depression on fear of falling, mobility, and balance in older male veterans.
• Interaction of some sterilizing filter materials with some technetium-99m radiopharmaceuticals.
• Intermittent 30s Intervals Performed at 100 and 70% VO2Peak Power (pVO2peak) Allow Trained Cyclists to Maintain VO2peak Longer than Continuous Intervals at 100% pVO2peak: 2417: Board #96 June 1 2:00 PM -3:30 PM.
• Kidney transplantation-second edition.
• Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients.
• Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
• Lysozyme, a mediator of sepsis, impairs the cardiac neural adrenergic response by nonendothelial release of NO and inhibitory G protein signaling.
• Nuclear spin selection rules for reactive collision systems by the spin-modification probability method.
• Patterns of salivary cortisol secretion in pregnancy and implications for assessment protocols.
• Pleural fluid exchange in rabbits.
• Prevalence of pleural effusions post orthotopic heart transplantation.
• Reply to DiMasi, Hansen, and Grabowski.
• Slowing of response time in young and middle-aged hypertensive patients.
• Subwatt threshold cw Raman fiber-gas laser based on H2-filled hollow-core photonic crystal fiber.
• The Excite Trial: Relationship of intensity of constraint induced movement therapy to improvement in the wolf motor function test.
• Two-dimensional array transducers using thick film connection technology.
• Unilateral lymphocytic pleuritis as a manifestation of familial mediterranean Fever.
• Values and structure in the German health care systems.
• [Effect of anti-vascular endothelial growth factor antibody on pleurodesis induced by transforming growth factor-beta or doxycycline in rabbits]